Horsemen's representatives told the Ohio Horse Racing Commission March 30 that equine medication rules, which the commission is reviewing, should be breed-specific in nature.
The New York Gaming Commission, during a Jan. 21 public hearing, heard the pros and cons of having different medication rules for Thoroughbred and Standardbred racehorses.
Amid another call for separate medication rules for Thoroughbreds and Standardbreds, the Ohio State Racing Commission has indicated it's not prepared to adopt a uniform national drug policy.
The United States Trotting Association, which in late September dropped out of the Racing Medication and Testing Consortium and rejected model medication rules approved by RCI, has created its own drug advisory committee.
The United States Trotting Association, citing differences in breeds, said Sept. 26 it has ended its membership in the Racing Medication and Testing Consortium and has rejected the proposed national model drug rules.
Most Popular Stories
- Capps' Death is Big Loss to Louisville Equine Program
- McCraken Finishes Strong in Five-Furlong Move
- Romans Mulling Rider Options for J Boys Echo
- Goldikova, Espinoza Among Hall of Fame Inductees
- Brisk Activity Bodes Well for OBS Spring Sale
- Albarado Fractures Lower Leg, Off J Boys Echo in Derby
- Santa Anita Cancels April 27 Racing
- Nichols Canyon Connections Pointing for Iroquois Bonus
- Spending Time With New Trainer Kent Sweezey
- OBS Hips to Watch Include Tapwrit's Half Brother